The influence of male pheromones on the contractile reactivity of the isolated superficial veins of the nose and face during the estrous cycle in gilts.
This study was designed to determine whether steroid sex pheromones of the boar may affect the contractile activity of the superficial venous vessels of the nose and face in gilts, and in this way contribute to recently discovered humoral transfer of pheromones to the brain and hypophysis. The dependence between the reactivity of nasal and facial veins to male pheromones and the phase of the estrous cycle in gilts was also studied. The gilts were used in the luteal phase of the cycle and in the follicular phase of the cycle. The dorsal nasal, frontal and facial veins were isolated on an appropriate day of the estrous cycle. The isolated rings of veins were treated with androstenone (5alpha-androst-16-en-3-one), androstenol (5alpha-androst-16-en-3-ol) and testosterone (17beta-hydroxy-4-androsten-3-one) in concentrations of 1 or 10 microM. Changes in the contractile activity of the isolated vein segments were measured using isometric transducer and recorded on HSE-ACAD software for Windows. Androstenone--main signaling boar pheromone--induced much stronger reactions of the vessels than androstenol. Androstenone caused significant relaxation of the dorsal nasal and frontal veins, and significant increased tension of the facial vein in the follicular phase of the estrous cycle. The results obtained suggest a direct effect of male pheromones on the contractile reactivity of the superficial veins of the nose and face in the female, and in this way contribute to a humoral pathway for transfer of pheromones to the brain and hypophysis. Moreover, the present study revealed changes in the reactivity during the estrous cycle of the veins, transporting blood from the region of the nasal cavity, to male pheromones participating in the regulation of female reproductive processes.
Grzegorzewski
W J
WJ
Institute of Animal Reproduction and Food Research of the Polish Academy of Sciences, Division of Reproductive Endocrinology and Pathophysiology, Department of Local Physiological Regulations, Tuwima 10, 10-747 Olsztyn, Poland. grzeg@pan.olsztyn.pl
D000736:Androstenes / Q000494:pharmacology; D000737:Androstenols / Q000494:pharmacology; D000818:Animals; D030762:Estrous Cycle / Q000502:physiology*; D005145:Face / Q000098:blood supply*; D005260:Female; D005498:Follicular Phase / Q000502:physiology; D066298:In Vitro Techniques; D008183:Luteal Phase / Q000502:physiology; D008297:Male; D009666:Nose / Q000098:blood supply*; D012724:Sex Attractants / Q000502:physiology*; D013552:Swine / Q000502:physiology*; D013739:Testosterone / Q000502:physiology; D014661:Vasoconstriction / Q000502:physiology; D014680:Veins / Q000502:physiology
D000736:Androstenes; D000737:Androstenols; D012724:Sex Attractants; D013739:Testosterone; C026828:5 alpha-androst-16-en-3 beta-ol